Banca
Pharmaceuticals and Healthcare Reports Japan Dyslipidemia Market Clique para ler
  • Comentários

Pharmaceuticals and Healthcare Reports

Japan Dyslipidemia Market

Publicado no e em "Saúde & Fitness, Saúde & Fitness", idioma — English. 3 páginas.
The launch of the proprotein convertase subtilisin/kexin type 9 (PCSK9) biologics and the cholesteryl ester transfer protein (CETP) inhibitors will reshape the sales landscape of the dyslipidemia market moving forward. Mais
Mostrar Tags
Etiquetas: japan dyslipidemia market analysis
Baixar
Assine GRÁTIS

Outras publicação de "Pharmaceuticals and Healthcare Reports"

Ver todas as publicações

Revistas Relacionadas